So the release of the NovoSeven reports as well as the two Avastin vs.

FORBES: Patient Safety and 'Off-Label' Drug Use

Off-label use of NovoSeven has previously raised concerns, partly because a drug that promotes formation of clots can increase risk of heart attacks and strokes.

WSJ: Hemophilia Drug's Off-Label Use Is Faulted

Case in point: two new reports looking at off-label use of the hemophilia drug NovoSeven and two soon-to-be-released studies comparing the off-label use of Avastin vs.

FORBES: Patient Safety and 'Off-Label' Drug Use